Leave the left atrial appendage untouched for stroke prevention!  by Stöllberger, Claudia et al.
indexed on Medline at the time of our
search, or it may have been available on
Medline but indexed incorrectly. Either
way, it highlights the limitations of elec-
tronic searches for the purpose of identify-
ing all relevant trials for meta-analyses.
One can never be certain that all trials have
been identified, and empiric evidence sug-
gests that up to 50% of relevant articles may
be missed despite vigilance in searching.3
As suggested by Takagi and colleagues,
we have added this trial to our meta-analysis
and would like to share the results to pro-
vide readers with the most current esti-
mates of clinical outcomes. Adding this
trial of MIDCAB versus PCI (n  100)
resulted in increased power and narrower
confidence intervals for the outcomes of
reintervention, death, stroke, angina recur-
rence, and myocardial infarction. The up-
dated results are provided in Table 1. Over-
all, none of the conclusions changed.
Regarding the suggestion that the trial
by Eefting and associates4 may introduce
heterogeneity, we performed a sensitivity
analysis by excluding this trial from the
analysis to determine the impact on results.
The results were not materially changed by
excluding Eefting. This may be because
similar results are achievable, whether the
procedure is delivered through OPCAB or
MIDCAB and whether single or multiple
vessels are anastomosed. On the other
hand, it may simply be that the analysis is
underpowered to detect important differ-
ences between subgroups. When the confi-
dence intervals around the nonsignificant
outcomes are examined, it is clear that im-
portant differences in outcomes have not been
ruled out, and further research will be re-
quired to enlighten any potential differ-
ences among subgroups. As Takagi and
colleagues have highlighted, the results of
this analysis should not be automatically
assumed to apply to OPCAB performed on
multivessel disease, inasmuch as this group
was underrepresented.
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Leave the left atrial appendage
untouched for stroke prevention!
To the Editor:
We read the article by Kamohara and col-
lesgues1 regarding the short-term and mid-
term effects of left atrial appendage (LAA)
occlusion on left atrial (LA) function with
great interest. An atrial exclusion device
was applied by means of thoracotomy in 19
mongrel dogs in sinus rhythm, and hemo-
dynamic, as well as echocardiographic,
data were recorded immediately and after 7
and 90 days. The authors found that LAA
exclusion might affect LA reservoir func-
tion. We would like to congratulate the
authors for their important study. However,
there still remain the following questions:
1. When measuring the LA area by
means of planimetry before LAA ex-
clusion, was the LAA area included
or excluded? If it was included, this
might well explain the decrease in LA
volume and area after LAA exclusion,
as listed in Table 1. If the LAA area
was not included, how do the authors
then explain the decrease in LA area
and volume?
2. There is a great variation in human
LAA size.2 We do not know whether
this is also true for the canine LAA.
What was the size of the excluded
LAAs, and was there any associa-
tion between LAA size and the he-
modynamic or Doppler measure-
ments?
3. The LAA is known as an important
site of natriuretic peptide secretion.3
Were serum levels of natriuretic pep-
tides measured before the procedure
and during follow-up? Did the au-
thors observe weight gain caused by
fluid retention after LAA occlusion?
4. It is known that in guinea pigs LAA
exclusion leads to a decrease in car-
diac output.4 If the investigated
dogs are still alive, it would be very
interesting to continue follow-up,
measure cardiac output and func-
tional parameters, and compare
them with those from control dogs
with the LAA left intact.
TABLE 1
Outcome OPCAB (%) PCI (%) OR (95% CI) I2 (%) P value for effect
Death, in hospital 1.1 0.4 1.88 (0.56–6.36) 0 .31
AMI, in hospital 2.7 2.8 1.04 (0.48–2.25) 0 .92
Stroke, in hospital 0.5 0.21 1.11 (0.35–2.49) 0 .64
Stroke, 1-5 y 0 1.3 0.34 (0.05–2.38) 0 .4
Angina recurrence, 1-5 y 11.7 22.8 0.44 (0.24–0.83) 38 .01
Reintervention, in hospital 2.3 3.4 0.74 (0.35–1.55) 0 .42
Reintervention, 1-5 y 5.3 19.1 0.23 (0.15–0.38) 0 .0001
OPCAB, Off-pump coronary artery bypass; PCI, percutaneous coronary intervention; OR, odds ratio; CI, confidence interval; AMI, acute myocardial
infarction.
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5. All hemodynamic and Doppler pa-
rameters were obtained in healthy
dogs in sinus rhythm at rest. Be-
cause LAA occlusion is considered
in patients with heart disease in
atrial fibrillation, an increase in
heart rate during exercise might
well result in an inappropriate in-
crease of the LA pressure because of
impaired LA reservoir function.
In conclusion, there is still no proof that
LAA occlusion prevents stroke,5 but hemo-
dynamically, this procedure might even do
harm and should therefore not be per-
formed in patients with atrial fibrillation.
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Reply to the Editor:
We appreciate the response of Drs Stöll-
berger, Schneider, and Finsterer to our work1
and thank them for their comments. Here are
our responses to their specific questions:
1. The left atrial appendage (LAA) area
was not included when measuring the
left atrial (LA) area. Slight changes in
LA area and volume measurements
might be expected due to the effect of
the LA body shape change caused by
occlusion of the LAA orifice. How-
ever, we have not detected any statis-
tically significant decreases in the LA
area or volume after LAA exclusion.
2. Although we did not measure the size
of the LAA in this series, we did
measure it in a more recent series of
16 dogs. The width and thickness of
the LAA orifice were 27.1 4.8 mm
(mean standard deviation) and 12.2
 4.3 mm, respectively. As indicated
by relatively small standard devia-
tions, there is not a great variation in
the LAA size in dogs.
3. Although we did not measure natri-
uretic peptide levels in this series, we
did measure atrial natriuretic peptide
and B-type natriuretic peptide levels
in a more recent series. There were no
significant changes in atrial natriuretic
peptide level (32  20 pg/mL at
baseline and 41  34 pg/mL after
30 days, P  .60) or B-type natriure-
tic peptide level (always 5 pg/mL).
We did not observe any weight gain
caused by fluid retention.
4. The investigated dogs were all
killed on the day of the terminal
study. During our follow-up period,
we did not observe any significant
decrease in stroke volume.
5. The effects of LAA occlusion on he-
modynamics in patients with heart
disease and in atrial fibrillation have
to be carefully investigated in the
future.
We disagree with their conclusion that he-
modynamically LAA occlusion might even
do harm and should therefore not be per-
formed in patients with atrial fibrillation.
There is no solid evidence to suggest that
exclusion of the LAA in patients with atrial
fibrillation does harm. In fact, there is good
evidence suggestive to the contrary2,3;
much of this has been gathered from pa-
tients undergoing mitral valve surgery or
surgical ablation. However, it is also clear
that surgical LAA ligation with current
techniques and technology is sometimes
incomplete. Such incomplete ligation might
be responsible for an increased risk of throm-
boembolic events after attempted ligation.4
Our focus is on the development of a method
for reliable, complete, and simple occlusion
of the LAA. With such an approach, we will
have the ability to study the clinical effects of
LAA exclusion. At this time, we believe that
such effects have not been fully elucidated.
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Selection of dialysis patients for
bilateral thoracic artery grafts
To the Editor:
I enjoyed the recent brief communication
“Gastric conduit staple line after esopha-
gectomy: To oversew or not?”1 This work
detailed two patients who had a minimally
invasive esophagectomy. During the proce-
dure, the gastric conduit staple line was not
oversewn or inverted. The first patient’s
staple line leak occurred on postoperative
day 1 and may have been related to a
stapler malfunction. The second staple line
leak occurred during the second postoper-
ative week and was probably due to multi-
ple factors.
I routinely oversew gastric staple lines
because of an experience with a young pa-
tient with renal failure, insulin-dependent di-
abetes, intravenous drug use, and supra-
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